ALX Oncology
ALXO
57 hedge funds and large institutions have $1.03B invested in ALX Oncology in 2020 Q3 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
73.71% more ownership
Funds ownership: 0% → 73.71% (+74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VP
venBio Partners
San Francisco,
California
|
+$381M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$166M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$123M |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$56.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$40.7M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $60K | +$62.2K | +1,583 | New |
|
52
Legal & General Group
London,
United Kingdom
| $40K | +$42.1K | +1,070 | New |
|
|
AIP
53
Ameritas Investment Partners
Lincoln,
Nebraska
| $31K | +$32.1K | +816 | New |
|
|
FMT
54
First Mercantile Trust
Cordova,
Tennessee
| $28K | +$23.6K | +600 | New |
|
55
Bank of Montreal
Toronto,
Ontario, Canada
| $16K | +$17.4K | +443 | New |
|
|
LC
56
Lindbrook Capital
Calabasas,
California
| $6K | +$5.9K | +150 | New |
|
|
AA
57
AlphaCentric Advisors
San Juan,
Puerto Rico
| $2K | +$1.97K | +50 | New |
|
ALXO Hedge Fund Activity: Q3 2020 in Review
57 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q3 2020, worth a combined $1.03B.
Buyers outnumbered sellers: 57 funds opened new ALXO positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was venBio Partners, opening a new position worth an estimated $381M.
- 57 institutional investors held ALX Oncology (ALXO) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $1.03B of ALX Oncology stock for Q3 2020.
- 57 funds opened new ALX Oncology positions in Q3 2020 and 0 closed out, a net change of +57 holders.
- The largest ALX Oncology buyer in Q3 2020 was venBio Partners, an estimated $381M added.
Based on aggregated 13F filings for Q3 2020.